Stocktoria
Kodiak Sciences Inc. KOD
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-04
Kodiak Sciences Inc. statistics & valuation
Market cap$2.2B
P / B14.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -65.4% | -52.5% | -54.3% | -50.1% | -29.5% |
| Return on equity | -146.1% | -117.2% | -98.0% | -76.5% | -40.3% |
| Current ratio | 4.72 | 6.72 | 6.93 | 9.26 | 11.36 |
Source: SEC EDGAR filings · CIK 0001468748 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.